Snehal Patel, the CEO and CFO of $GLSI ($GLSI), bought 2,400 shares of the company on 12-31-2024. This trade was reported by Quiver Quantitative using data from a ...
Greenwich LifeSciences is continuing to develop a HER2 vaccine for HER2-positive breast cancer. Recently announced data give a preliminary glimmer that the vaccine is doing something in patients, but ...
Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01. Discover the top trade setups and strategies ...
Greenwich LifeSciences (NASDAQ:GLSI) added ~23% in the premarket on Wednesday after the company posted preliminary immune response data from a Phase 3 clinical trial for GLSI-100, a vaccine designed ...
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) shares are trading higher Monday after the company announced it extended its lock-up period to Sept. 30, 2026. What To Know: Greenwich LifeSciences said its ...
Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.
Asianet Newsable on MSN
Why is GLSI stock rising today?
Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results